Covered recipient · General Payments record
JAY S LIPSHITZ
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2019–2025
$3,788.62
- Reported across 182 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $176.22 | 8 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $44.64 | 2 |
| Daiichi Sankyo Inc. | $29.76 | 1 |
| Agios Pharmaceuticals, Inc. | $24.10 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.37 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.96 | 1 |
| Janssen Biotech, Inc. | $19.15 | 1 |
| Syndax Pharmaceuticals, Inc. | $16.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. | $24.10 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1253245642 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.96 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1225627370 | CMS |
| Daiichi Sankyo Inc. | $29.76 | 04/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197062573 | CMS |
| Janssen Biotech, Inc. | $19.15 | 02/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175395226 | CMS |
| Novartis Pharmaceuticals Corporation | $22.42 | 01/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200638337 | CMS |
| Novartis Pharmaceuticals Corporation | $22.22 | 03/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200638339 | CMS |
| Syndax Pharmaceuticals, Inc. | $16.24 | 01/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238992898 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.37 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223877122 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.